Is High Volume HDF cost-effective? Cost-Effectiveness Analysis helps healthcare decision-makers evaluate whether a new treatment is worth funding by comparing the clinical benefits to the costs. The CONVINCE trial conducted a Cost-Utility Analysis to compare high-volume hemodiafiltration with standard high-flux hemodialysis in 8 European countries. The results suggest that high-volume HDF is cost-effective in many healthcare systems, with a high probability of meeting Willingness-to-Pay thresholds.
Event Date: 5/28/2025